Abstract:Background Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human embryonic stem cells (hESCs) towards endothelial lineage, differentiation into arterial and venous endothelial phenotypes remains elusive. Additionally, current differentiation strategies are hampered by inefficiency, lack of reproducibility, and use of animal-derived products. Methods To direct the differentiation of hESCs to endothelial subtypes, H1- and H9-hESCs were seeded on human plasma fibronectin and differentiated under chemically defined conditions by sequential modulation of glycogen synthase kinase-3 (GSK-3), basic fibroblast growth factor (bFGF), bone morphogenetic protein 4 (BMP4) and vascular endothelial growth factor (VEGF) signaling pathways for 5 days. Following the initial differentiation, the endothelial progenitor cells (CD34 + CD31 + cells) were sorted and terminally differentiated under serum-free conditions to arterial and venous ECs. The transcriptome and secretome profiles of the two distinct populations of hESC-derived arterial and venous ECs were characterized. Furthermore, the safety and functionality of these cells upon in vivo transplantation were characterized. Results Sequential modulation of hESCs with GSK-3 inhibitor, bFGF, BMP4 and VEGF resulted in stages reminiscent of primitive streak, early mesoderm/lateral plate mesoderm, and endothelial progenitors under feeder- and serum-free conditions. Furthermore, these endothelial progenitors demonstrated differentiation potential to almost pure populations of arterial and venous endothelial phenotypes under serum-free conditions. Specifically, the endothelial progenitors differentiated to venous ECs in the absence of VEGF, and to arterial phenotype under low concentrations of VEGF. Additionally, these hESC-derived arterial and venous ECs showed distinct molecular and functional profiles in vitro. Furthermore, these hESC-derived arterial and venous ECs were nontumorigenic and were functional in terms of forming perfused microvascular channels upon subcutaneous implantation in the mouse. Conclusions We report a simple, rapid, and efficient protocol for directed differentiation of hESCs into endothelial progenitor cells capable of differentiation to arterial and venous ECs under feeder-free and serum-free conditions. This could offer a human platform to study arterial–venous specification for various applications related to drug discovery, disease modeling and regenerative medicine in the future.

Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture.

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Differentiation of Human Embryonic Stem Cells Toward the Chondrogenic Lineage.

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

Wnt Signaling Modulates Routes of Retinoic Acid-Induced Differentiation of Embryonic Stem Cells

All-Trans Retinoic Acid Promotes Smooth Muscle Cell Differentiation of Rabbit Bone Marrow-Derived Mesenchymal Stem Cells

Differentiation and Enrichment of Expandable Chondrogenic Cells from Human Embryonic Stem Cells in Vitro

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

Derivation of multipotent nestin + /CD271 − /STRO-1 − mesenchymal-like precursors from human embryonic stem cells in chemically defined conditions

Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells.

Identification and function assessment of smooth muscle cells derived from mouse embryonic stem cells

Differentiation of Adipose-Derived Stem Cells into Contractile Smooth Muscle Cells Induced by Transforming Growth Factor-Beta 1 and Bone Morphogenetic Protein-4

Primary Study of Human Embryonic Stem Cell on Differentiation of Vascular Endothelial Cells

Human Hair Follicle Stem Cell Differentiation into Contractile Smooth Muscle Cells is Induced by Transforming Growth Factor-Β1 and Platelet-Derived Growth Factor BB.

CREG Ameliorates Embryonic Stem Cell Differentiation into Smooth Muscle Cells by Modulation of TGF-β Expression

The Mechanism of Stem Cell Differentiation into Smooth Muscle Cells

Abstract 650: Stem Cell-derived SMCs Are Useful for Vascular Tissue Engineering

Abstract 241: Retinoic Acid Promotes Metabolic Maturation of Human Embryonic Stem Cell-derived Cardiomyocytes

Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds.

Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds

Transdifferentiation of human endothelial progenitors into smooth muscle cells